COMPUTER FORECASTING AND EXPERIMENTAL VALIDATION OF ANTIAGGREGATE PROPERTIES OF CETRINE, GLURENORM, MOEX AND DILTHIAZEM

COMPUTER FORECASTING AND EXPERIMENTAL VALIDATION OF ANTIAGGREGATE PROPERTIES OF CETRINE, GLURENORM, MOEX AND DILTHIAZEM

Show other versions (1)

A new algorithm and 'Drug' database, permitting to predict new actions of familiar medical products, are developed and registered. The algorithm is based on comparison of a set of quantum-chemical and geometrical descriptors of molecules through multivariate statistics. The algorithm outpu...

Full description

Bibliographic Details
Main Author:	Nikolay P. Votintsev
Format:	Article
Language:	Russian
Published:	Don State Technical University 2011-03-01
Series:	Advanced Engineering Research
Subjects:	biological activity forecasting molecular modeling nonpeptide inhibitors of iib/iiia thrombocytic glycoproteins.
Online Access:	https://www.vestnik-donstu.ru/jour/article/view/724

Similar Items

COMPUTER FORECASTING AND EXPERIMENTAL VALIDATION OF ANTIAGGREGATE PROPERTIES OF CETRINE, GLURENORM, MOEX AND DILTHIAZEM
by: Nikolay P. Votintsev
Published: (2018-07-01)

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01)

Identification and Characterization of Glanzmann Thrombasthenia in 2 Closely Related Mixed‐breed Dogs
by: L.Z. Haysom, et al.
Published: (2016-03-01)

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
by: Muhammad Shabbir Rawala, et al.
Published: (2020-03-01)

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials
by: Vincent Roule, et al.
Published: (2017-02-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01)

Scorpion envenomation-induced acute thrombotic inferior myocardial infarction
by: Ahmet Oytun Baykan, et al.
Published: (2016-02-01)

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

A novel ITGA2B double cytosine frameshift variant (c.1986_1987insCC) leads to Glanzmann's thrombasthenia in a cat
by: Victor N. Rivas, et al.
Published: (2024-05-01)

Ex vivo STUDY OF THE ACTION OF INTEGRIN RECEPTORS ANTAGONIST FROM ECHIS MULTISQUAMATIS SNAKE VENOM ON PLATELETS OF PREGNANT WOMEN WITH COMPICATIONS DURING GESTATION
by: O. M. PLATONOV, et al.
Published: (2023-04-01)

Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
by: Salma Abdeladim, et al.
Published: (2021-01-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Dynamics of hemostasis system parameters in assessing the risk of complications in the patients with acute myocardial infarction receiving antiplatelet therapy
by: T. R. Gvindzhiliya, et al.
Published: (2024-09-01)

Management of immediate partial bioresorbable vascular scaffold stent thrombosis
by: Ziad Said Dahdouh, et al.
Published: (2017-03-01)

Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors
by: Hamidreza Hekmat, et al.
Published: (2022-09-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
by: Salam Amar M, et al.
Published: (2001-07-01)

Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
by: Giuseppe De Luca, et al.
Published: (2024-09-01)

Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
by: Dimitrios Alexopoulos, et al.
Published: (2018-04-01)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
by: JongSung Hahn, et al.
Published: (2023-07-01)

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
by: Wonjae Lee, et al.
Published: (2018-10-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis
by: Lili Sun, et al.
Published: (2020-06-01)

Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention – A single centre observational study
by: Upendra Kaul, et al.
Published: (2015-07-01)

Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction
by: Tarek M. Zaki, et al.
Published: (2011-06-01)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017-07-01)

Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea
by: Lorenzo Pradelli
Published: (2005-12-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
by: Ze-Mu Wang, et al.
Published: (2023-10-01)

Glanzmann thrombasthenia associated with human immunodeficiency virus-positive patient
by: Rakesh Kumar Manne, et al.
Published: (2014-01-01)

Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial
by: Jia Liao, et al.
Published: (2024-09-01)

Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual Antiplatelet Therapy
by: Valeria V. Bodrova, et al.
Published: (2024-10-01)

A rare case of eptifibatide-induced thrombocytopenia
by: Khalil Kamar, et al.
Published: (2021-03-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)

Assessment of Fibrinogen Macromolecules Interaction with Red Blood Cells Membrane by Means of Laser Aggregometry, Flow Cytometry, and Optical Tweezers Combined with Microfluidics
by: Alexey N. Semenov, et al.
Published: (2020-10-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

Implications of troponin testing in clinical medicine
by: Meinertz Thomas, et al.
Published: (2001-04-01)

Tirofiban-induced thrombocytopenia
by: Jun Wang, et al.
Published: (2023-12-01)

Activation‐induced changes in platelet surface receptor expression and the contribution of the large‐platelet subpopulation to activation
by: Masaaki Moroi, et al.
Published: (2020-02-01)

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women
by: Grzegorz Stachowiak, et al.
Published: (2015-02-01)